The 68-Year-Old with an Infected Total Knee and Multiple Comorbidities
A 68-year-old woman presents 14 months after a primary total knee arthroplasty with 3 weeks of increasing knee pain, swelling, and a sinus tract draining serous fluid. She has rheumatoid arthritis on methotrexate and low-dose prednisone, type 2 diabetes (HbA1c 8.4%), and chronic kidney disease (eGFR 35). Aspiration grows methicillin-resistant Staphylococcus aureus. She is systemically well, afebrile, with a normal white count. Inflammatory markers are elevated (CRP 88, ESR 62). She asks whether she can keep her knee and just take antibiotics, because she 'cannot afford another surgery.'
1. What is the appropriate surgical strategy, and why is antibiotic suppression alone inappropriate here?
Read the worked answer
The presence of a sinus tract with a draining wound and a positive aspirate for MRSA establishes chronic prosthetic joint infection, and a sinus tract is one of the classic indications for removal of the prosthesis - suppressive antibiotics alone will not cure a chronic biofilm infection, and a draining sinus is a persistent source of sepsis risk. The standard of care is a two-stage exchange: stage 1 resection arthroplasty with thorough debridement and an antibiotic-loaded cement spacer, followed by 6 weeks (or longer) of organism-directed IV antibiotics, then stage 2 reimplantation once markers normalize and the wound is quiescent. A one-stage exchange is generally reserved for selected patients with a known, susceptible organism and good soft tissues - not ideal here with MRSA, a sinus tract, and immunosuppression. DAIR (debridement, antibiotics, implant retention) is inappropriate for a chronic infection with a sinus tract and 14 months of implantation. I would explain that antibiotics alone would suppress but not cure, and that the sinus tract makes this a chronic, established infection.
2. How do her rheumatoid arthritis, methotrexate, steroids, diabetes, and renal function change your perioperative plan?
Read the worked answer
Each comorbidity changes management. Methotrexate and prednisone cause immunosuppression and impair wound healing and infection control; I would coordinate with rheumatology to hold methotrexate perioperatively (typically around surgery, per rheumatology guidance) while recognizing that steroid stress dosing may be needed and that steroid withdrawal risks a rheumatoid flare. Diabetes with HbA1c 8.4% increases reinfection risk at both stages; I would involve endocrinology to optimize glucose before stage 2 and accept that stage 1 may need to proceed urgently. CKD with eGFR 35 constrains antibiotic choice and dosing - many antibiotics (e.g., vancomycin, aminoglycosides) require renal dose adjustment and monitoring, and cement spacer antibiotic loading must be chosen with renal toxicity in mind (avoid high-dose aminoglycoside in renal failure). I would also consider her functional status and goals: a two-stage exchange is a long, morbid process, and in a frail patient with multiple comorbidities, resection arthroplasty or amputation may be a legitimate discussion if she cannot tolerate two stages. The judgement point is that infection control is the priority, but the strategy must be individualized to her physiology, not applied reflexively.